S4670 Dieulafoy Lesion in a Post–Deceased Donor Liver Transplant Patient: A Rare Cause of Upper GI Bleeding

Introduction: Dieulafoy lesions, characterized by a large-caliber submucosal artery eroding the mucosa in the absence of ulceration, are an uncommon but serious cause of upper gastrointestinal bleeding. We report a rare case of a bleeding Dieulafoy lesion in a post–liver transplant patient, representing 1 of only 2 such cases documented in the literature. Case Description/Methods: A 74-year-old man with a history of chronic hepatitis B infection and hepatocellular carcinoma status post deceased donor liver transplant (2021) with post-transplant course complicated by ischemic cholangiopathy, recurrent portal hypertension presented with a hemoglobin of 5.8 (baseline 8-9) on routine labs without overt signs of bleeding. Other remarkable labs included platelets 230, BUN 30, Cr 1.8 (baseline), Tbili 2.7, DBili 1.8, and albumin 2.6. Aminotransferase levels, hemolysis, and coagulation labs were unremarkable. He endorsed fatigue and dark brown stools 1 week prior to arrival. On exam, he was tachycardic, with otherwise normal vital signs and negative DRE. He had bilateral lower extremity edema, abdominal distention with fluid wave, and mild pallor on exam. The patient was transfused 2 units of pRBCs and started on an octreotide infusion and pantoprazole. Push enteroscopy was remarkable for LA Grade D reflux and erosive esophagitis, and a bleeding Dieulafoy lesion with active hemorrhage at the gastric cardia. Hemostasis was successfully achieved with hemostatic clips and thermocautery. Discussion: Dieulafoy lesions are often missed in the absence of active bleeding, given their subtle mucosal appearance, which can present as a raised nipple, visible vessel, or just normal appearing mucosa with no ulceration. Though pathogenesis is incompletely understood, portal hypertension and mucosal ischemia have been implicated. In our post–liver transplant patient with cellular rejection and portal hypertension, altered hemodynamics may have contributed to angiogenesis as well as remodeling of the existing vasculature. Further studies are required to investigate the relationship of these lesions in this patient population.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001146140.35893.62
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4670 Dieulafoy Lesion in a Post–Deceased Donor Liver Transplant Patient: A Rare Cause of Upper GI Bleeding

Ushan A. Ranasinghe, Edward Villa, Raza Muhammad, Joseph Ahn
The American Journal of Gastroenterology
Gastrointestinal Bleeding Diagnosis and Treatment
article

S4670 Dieulafoy Lesion in a Post–Deceased Donor Liver Transplant Patient: A Rare Cause of Upper GI Bleeding

Ushan A. Ranasinghe, Edward Villa, Raza Muhammad, Joseph Ahn
article en

Abstract

Introduction: Dieulafoy lesions, characterized by a large-caliber submucosal artery eroding the mucosa in the absence of ulceration, are an uncommon but serious cause of upper gastrointestinal bleeding. We report a rare case of a bleeding Dieulafoy lesion in a post–liver transplant patient, representing 1 of only 2 such cases documented in the literature. Case Description/Methods: A 74-year-old man with a history of chronic hepatitis B infection and hepatocellular carcinoma status post deceased donor liver transplant (2021) with post-transplant course complicated by ischemic cholangiopathy, recurrent portal hypertension presented with a hemoglobin of 5.8 (baseline 8-9) on routine labs without overt signs of bleeding. Other remarkable labs included platelets 230, BUN 30, Cr 1.8 (baseline), Tbili 2.7, DBili 1.8, and albumin 2.6. Aminotransferase levels, hemolysis, and coagulation labs were unremarkable. He endorsed fatigue and dark brown stools 1 week prior to arrival. On exam, he was tachycardic, with otherwise normal vital signs and negative DRE. He had bilateral lower extremity edema, abdominal distention with fluid wave, and mild pallor on exam. The patient was transfused 2 units of pRBCs and started on an octreotide infusion and pantoprazole. Push enteroscopy was remarkable for LA Grade D reflux and erosive esophagitis, and a bleeding Dieulafoy lesion with active hemorrhage at the gastric cardia. Hemostasis was successfully achieved with hemostatic clips and thermocautery. Discussion: Dieulafoy lesions are often missed in the absence of active bleeding, given their subtle mucosal appearance, which can present as a raised nipple, visible vessel, or just normal appearing mucosa with no ulceration. Though pathogenesis is incompletely understood, portal hypertension and mucosal ischemia have been implicated. In our post–liver transplant patient with cellular rejection and portal hypertension, altered hemodynamics may have contributed to angiogenesis as well as remodeling of the existing vasculature. Further studies are required to investigate the relationship of these lesions in this patient population.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 45%
Gastrointestinal Bleeding Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.